Electroconvulsive therapy in the setting of implantable cardioverter-defibrillators

Journal of ECT

Volumn 25, Issue 3, 2009, Pages 198-201

  Davis, Asha ^a   Zisselman, Marc ^b,c   Simmons, Tony ^a   McCall, W Vaughn ^a   McCafferty, John ^b,c   Rosenquist, Peter B ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Cardiovascular disease; Elderly; Electroconvulsive therapy; Heart failure; ICD; Implantable cardioverter defibrillator; Major depression; Pacemakers

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; DULOXETINE; ESCITALOPRAM; ESMOLOL; GLYCERYL TRINITRATE; LAMOTRIGINE; MIDAZOLAM; MIRTAZAPINE; NORTRIPTYLINE; SERTRALINE; VENLAFAXINE; WARFARIN;

AGED; ANHEDONIA; AORTA STENOSIS; ARTICLE; BIPOLAR DISORDER; CARDIOMYOPATHY; CASE REPORT; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; ELECTROCONVULSIVE THERAPY; FEMALE; HEART INFARCTION; HUMAN; MAJOR DEPRESSION; MALE; MITRAL VALVE STENOSIS; PEROPERATIVE CARE; RESTLESSNESS;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES;

EID: 70349126283     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31819069d5     Document Type: Article

References (23)

1. Zielinski RJ, Roose SP, Devanand DP, et al. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry. 1993;150:904-909.
2. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005;111:250-253.
3. Koenig HG. Differences between depressed patients with heart failure and those with pulmonary disease. Am J Geriatr Psychiatry. 2006;14:211-219.
4. Frasure-Smith N, Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med. 2005;67:S19-S25.
5. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI). Arch Intern Med. 2004;164:289-298. (Pubitemid 38176467)
6. Bremmer MA, Hoogendijk WJG, Deeg DJH, et al. Depression in older age is a risk factor for first ischemic cardiac events. Am J Geriatr Psychiatry. 2006;14:523-530.
7. Reynolds CF III, Dew MA, Lenze EJ, et al. Preventing depression in medical illness: a new lead? Arch Gen Psychiatry. 2007;64: 884-885.
8. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med. 2007;167:367-373.
9. Mykletun A, Bjerkeseto O, Dewey M. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007;69: 323-331.
10. Dyrda K, Khairy P. Implantable rhythm devices and electromagnetic interference: myth or reality? Expert Rev Cardiovasc Ther. 2008;6: 823-832.
11. Rastogi S, Goel S, Tempe D, et al. Anaesthetic management of patients with cardiac pacemakers and defibrillators for noncardiac surgery. Ann Card Anaesth. 2005;8:21-32.
12. Almeida OP, Flicker L, Norman P, et al. Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry. 2007;15:506-513.
13. Hecksel KA, Bostwick JM. Getting to the heart of his 'shocking' trauma: Mr. J. would rather die than live in fear of defibrillator jolts. Curr Psychiatry. 2007;6:84-95.
14. Lewin RJP, Frizelle DJ, Kaye GC. A rehabilitative approach to patients with internal cardioverter-defibrillators. Heart. 2001;85: 371-372.
15. Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrythymia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999;9:163-168.
16. Pinski SL, Trohman RG. Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist. Ann Intern Med. 1995;122:770-777.
17. Dolenc TJ, Barnes RD, Hayes DL, et al. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27: 1257-1263.
18. Lapid MI, Rummans TA, Hofmann VE, et al. ECT and automatic internal cardioverter-defibrillator. J ECT. 2001;17:146-148.
19. Pornnoppadol C, Isenberg KI. ECT with implantable cardioverter defibrillator. J ECT. 1998;14:124-126.
20. McCall WV, Shelp FE, Weiner RD, et al. Effects of labetalol on hemodynamics and seizure duration during ECT. Convuls Ther. 1991;7:5-14.
21. Zvara DA, Brooker RF, McCall WV, et al. The effect of esmolol on ST-segment depression and arrythmias after electroconvulsive therapy. Convuls Ther. 1997;13:165-174.
22. McCall WV. Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry. 1996;57:199-203.
23. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2007; 50:1707-1732.